Non-Hodgkin's lymphoma invades the brain ... but most patients relapse, and the 5-year survival rate remains inferior to that of patients over 60 years of age with DLBCL outside the nervous ...

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

Navigating the Shifting Terrain of Diffuse Large B-Cell Lymphoma Treatment: Insights for Early-Career Physicians Dr Kami Maddocks advises early-career physicians regarding the evolution of DLBCL ...

The five-year relative survival rate for stage 4 Hodgkin lymphoma is 81 percent, and 64 percent for stage 4 non-Hodgkin lymphoma. Everyday Health follows strict sourcing guidelines to ensure the ...

Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

Follicular lymphoma is the second most common form of non-Hodgkin lymphoma (NHL), and is ... and it has a five-year survival rate of only 20% for patients in the third line and later.